A receptor map of serotonin distribution is integrated into a model of the dynamic activity of the brain under the effects of LSD. The approach opens new avenues to understand experimental manipulations of healthy brain activity and offers a novel drug-discovery platform.
The absence of any prevailing imposition on cognitive function allows the opportunity to plan and prospect, ruminate, replay and process memories or dissociate from the present. These quintessentially personal thought processes spontaneously alternate and vary in intensity and highlight the dynamic nature of brain activity, even when 'resting' [1] . Such dynamics can be captured via 'resting state' functional magnetic resonance imaging (fMRI) acquisitions, yielding an assay of spontaneous brain activation and its temporal variability. Intriguingly, despite the untethered nature of these acquisitions, there exists considerable consistency in the way the brain 'dwells' in particular configurations (or 'states'), the transitions between states and the re-visiting of recurrent states [2] . Various metrics of state transitions and functional connectivity dynamics can be extracted from these data, yielding summary statistics for external validation [3] . These metrics of functional connectivity dynamics appear to be stable across sessions within subjects, and even between subjects [4] . While providing unique insights into what our brains do 'at rest', there nonetheless exists an upper limit on what can be learned about the brain by simply measuring its spontaneous activity [5] . System perturbations (electrical, biochemical) and computational models can help here [6] : In this issue of Current Biology, Kringelbach et al. [7] address this impasse by administering the serotonin receptor agonist lysergic acid diethylamide (LSD) to healthy volunteers and studying the resulting perturbation of resting state brain activity with a whole brain biophysical model. We review the fundamentals of this study and consider its stated ambition to Current Biology 28, R1143-R1163, October 8, 2018 ª 2018 Elsevier Ltd. R1157
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Dispatches provide a novel computational drug design platform.
LSD molecules are structurally similar to serotonin, such that the receptor folds around it like a 'lid': the firing rate of the neurons then increases, as long as the molecule is trapped inside [8] . A single dose of LSD is usually administered via a blotter paper strip held under the tongue and comprises anywhere from 15 up to 100 mgrams of LSD; in this study 75 mgrams was intravenously applied. The cognitive effects of LSD (a 'trip') commence about an hour after administration and last for up to 5 hours. During this period, users experience a wide variety of effects, most often visual and other sensory distortions, changes to the quality and attribution of internal thoughts, intense emotions including euphoria, synesthesia ('hearing' colors or 'seeing' music) and, occasionally, surprising new insights about life. Brain dynamics correspondingly change: Kringelbach et al. observe that time-averaged functional connectivity changes, as does a metric of functional connectivity dynamics, which is sensitive to the recurrence of neural states. Brain dynamics during passive music listening -deployed to heighten the trip -also change.
This assay of perturbed brain activity under the influence of LSD provides a target for Kringelbach et al. to address with a biophysical model. Rather than modelling brain activity at the level of individual neurons, they employ a 'mass action' approach that has a deeply entrenched role in physics (for everything from gases and magnets to swarming ants and mosh pits [9] ) and hence model the average 'mean field' activity of populations of neurons [10] . Just as pressure and temperature summarize the kinetics of thousands of gas molecules, so do population-level mean firing rates, conductances and membrane potentials capture the collective action of thousands of cells in a local population of neurons (for a review, see e.g. [11] ). In this manner, the dimensionality of a neuronal population model is reduced from thousands to half a dozen or less [12] (Figure 1) . A whole-brain model is then constructed from these mesoscopic populations by coupling an ensemble of them according to an appropriate structural 'connectome' (a wiring diagram), such as derived from tracer studies in primates [13] or from diffusion MRI data in humans [14] . Although this approach clearly loses the fidelity afforded to single neuron-based models, it yields a dynamic brain network model which is more tractable, is 'identifiable' and, crucially, is matched to the aperture of large-scale data such as fMRI and EEG [11] . The model used by Kringelbach et al. thus incorporates our understanding of neural firing in local circuits, taken in a reduced mathematical form, and combines this with knowledge of how different brain structures are connected to each other. Such approaches have been shown to approximate empirical resting state fMRI data from healthy participants through tuning the strength of the inter-system coupling function (which governs the mutual influence amongst connected populations) to an optimal 'working point' [13, 14] .
The first reason why the administration of LSD by Kringelbach et al. is important to this field is that it expands the framework to model a brain that is not 'normal'. In this case, to first order, the model was validated against brain activity under the influence of LSD by tuning the inter-node coupling function to fit time-averaged resting state functional connectivity. This has ramifications for the study of psychiatric disorders, such as depression, obsessive compulsive disorder or anxiety. While the changes in brain dynamics in these disorders are more entrenched, the biochemical and/or structural mechanisms are amenable to the same approach [15, 16] .
Most psychiatric disorders are associated with dysfunction in a neurotransmitter, and this brings us to the second reason why this study is important. The authors advanced upon existing dynamic brain network models by taking into account a modulation in the brain's serotonergic system. First, regionspecific values of serotonin concentration were extracted from a recently published atlas of the human serotonin system obtained by positron emission tomography (PET) [17] . This was integrated into the dynamic brain network model as a regional modulation of the 'neural gain' of individual populations. In addition, a global parameter was introduced to allow for global up-or down-tuning of these regional neural gains, to mirror the impact of the brain under LSD. Neural gain captures how quickly the efferent firing rate of a neural population responds to changes in afferent input. Only recently has the gain function in dynamic brain network models been subject to parametric manipulation [18] . The paper of Kringelbach et al. represents a first in the use of independent data to inform the regional heterogeneity of this important effect (Figure 2) .
The authors found that their 'enhanced' dynamic brain network model could fit the brain's faster, more unstable dynamics (as quantified by the functional connectivity dynamics) better than a standard regionally homogenous approach. That is, they used the higher order statistics of brain dynamics to better triangulate the model parameters and found that the heterogeneous gain tuning improves model fit. Importantly, by benchmarking against randomly permuted PET maps, they showed that the specific distribution of serotonin was crucial to obtain this better fit (which was hence not due to a trivial increase in the model complexity). Now, for the first time, structural connectivity and empirical neurotransmitter distribution are both used to model realistic predictions regarding the brain's dynamic behavior. The implication is that this enhanced BDN modelling approach could include also other neurotransmitters on the path to modeling the brain in the presence of disease. And, when an abnormally functioning brain can be restored to normal brain function by changing regional neurotransmitter values, this could be of great value for designing novel pharmacological interventions to ameliorate psychiatric burden. Such is their proposed computational drug design platform. Other interventions, such as novel brain stimulation therapies (e.g. new sites for transcranial magnetic stimulation [6] ) could also be tested using this platform.
One feature of the model is its relative simplicity. The brain is a vastly complex organ with billions of neurons connected in myriad ways. As above, the authors use a reduced full-brain model, consisting of (only) 90 regional models that each describe the behavior of a large collection of neurons. Other simulators exist, such as BRIAN (http://briansimulator.org), but these are so complex that to model the brain completely would be computationally prohibitive and, arguably, impossible to identify the best combination of physiological parameters to fit the data. The uniqueness of the BDN model over other more computationally heavy models is that structural, whole-brain connectivity measures are integrated into the model and it can still run on a single cluster within a reasonable time.
Kringelbach et al. thus establish an important new landmark. However, several limitations pertain. Most crucially, the authors use a compilation of group averaged data (PET, rs-fMRI, diffusion MRI) each from different sources. Moving toward individual differences and a 'precision psychiatry' approach will require that these data are acquired from the same subjects and a single-subject approach is used. Naturally, this in turn relies upon improvements in the acquisition and processing of these data.
A real and exciting means of improving the metrics of brain dynamics is to use simultaneous EEG-fMRI. As it stands, only the functional connectivity dynamics is used -a metric obtained from slow BOLD data. With a change in the 'observation function', the model in this work can also model EEG variability [19] . This would uniquely and more robustly allow validation of the model's assumptions regarding the firing of neurons. Finally, the use of parameter tuning and model fit using simple methods has important limitations. A variational, Bayes-based approach would allow a more principled way of balancing model likelihood and model complexity [20] . Figure 2 . A schematic representation of the components that constitute the modelling framework.
Top: the parcellation scheme segments gray matter into discrete neural populations, and the diffusion-MRI-derived tractography informs the connectivity strength between them, yielding a dynamic brain network model (middle; adapted from [11] ). The innovation in Kringelbach et al. lies in the region-specific modification of neural gain as informed by the PET-derived serotonin atlas [17] . This allows the model to run simulations with a global scaling of the neural gains to match data that were acquired under the influence of LSD (bottom). This validates the inclusion of regionspecific neural gain obtained from PET imaging into the model.
